Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.

Read Time:5 Second

Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

5 Star

4 Star

3 Star

2 Star

1 Star

(Add your review)

China Vanke posted a first-quarter loss as earnings were weighed by the ongoing slump in China’s property sector.

Peacock is raising prices again, a year after its last price hike and just in time for the Summer Olympics.

Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms...

The past few months haven’t been so easy on the Nvidia Corp. wannabes, and AMD will look to reset that...

Shares of Coursera Inc. and Chegg Inc. fell in the after-hours session Monday after both education-tech companies guided for weaker...

AT&T’s decisions in recent years look better than those made by rivals, according to Barclays.